Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08JAN
|
|||
| Former ID |
DIB006398
|
|||
| Drug Name |
Cipatinib
|
|||
| Synonyms |
HER-1/HER-2 inhibitor (oral, cancer), Jiangsu Hengrui
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Jiangsu Hengrui Medicine Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01301911) Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.